Alkeon Capital Management LLC Axsome Therapeutics, Inc. Transaction History

Alkeon Capital Management LLC

  • $58.2 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020
SELL
$16.71 - $106.24 $1.67 Million - $10.6 Million
-100,000 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$13.46 - $25.75 $269,200 - $515,000
20,000 Added 25.0%
100,000 $2.58 Million
Q1 2019

May 15, 2019
BUY
$2.63 - $16.34 $210,400 - $1.31 Million
80,000 New
80,000 $1.14 Million

Others Institutions Holding AXSM

# of Institutions
325
Shares Held
37.7M
Call Options Held
912K
Put Options Held
855K
View Full List

About Axsome Therapeutics, Inc.

AXSM Quotes by TradingView
  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $3.73B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Alkeon Capital Management LLC Portfolio

Follow Alkeon Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alkeon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alkeon Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email